American Association for Cancer Research
Browse

Figure S5 from Microenvironmental Cues Determine Tumor Cell Susceptibility to Neutrophil Cytotoxicity

Download (2.99 MB)
journal contribution
posted on 2023-03-31, 03:46 authored by Maya Gershkovitz, Tanya Fainsod-Levi, Saleh Khawaled, Merav E. Shaul, Ronit V. Sionov, Leonor Cohen-Daniel, Rami I. Aqeilan, Yoav D. Shaul, Zvi G. Fridlender, Zvi Granot
<p>Supplemental Figure S5. Metastatic seeding of BMP7 treated cells is not enhanced by neutrophil depletion in tumor baring mice. Representative images of lung associated GFP+ BMP7 treated cells in control (BMP7) and neutrophil depleted (BMP7 depletion) mice, 48 hrs following tail-vein injection.</p>

History

ARTICLE ABSTRACT

We have recently shown that neutrophil antitumor cytotoxicity is Ca2+ dependent and is mediated by TRPM2, an H2O2-dependent Ca2+ channel. However, neutrophil antitumor activity is dependent on context and is manifested in the premetastatic niche, but not at the primary site. We therefore hypothesized that expression of TRPM2 and the consequent susceptibility to neutrophil cytotoxicity may be associated with the epithelial/mesenchymal cellular state. We found that TRPM2 expression was upregulated during epithelial-to-mesenchymal transition (EMT), and mesenchymal cells were more susceptible to neutrophil cytotoxicity. Conversely, cells undergoing mesenchymal-to-epithelial transition (MET) expressed reduced levels of TRPM2, rendering them resistant to neutrophil cytotoxicity. Cells expressing reduced levels of TRPM2 were protected from neutrophil cytotoxicity and seeded more efficiently in the premetastatic lung. These data identify TRPM2 as the link between environmental cues at the primary tumor site, tumor cell susceptibility to neutrophil cytotoxicity, and disease progression. Furthermore, these data identify EMT as a process enhancing tumor-cell immune susceptibility and, by contrast, MET as a novel mode of immune evasion.Significance: EMT is required for metastatic spread and concomitantly enhances tumor cell susceptibility to neutrophil cytotoxicity. Cancer Res; 78(17); 5050–9. ©2018 AACR.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC